The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes

BACKGROUND: A delay in reaching HbA1c targets in patients with newly-diagnosed type 2 diabetes (T2D) is associated with an increased long-term risk of developing cardiovascular diseases (CVD), a phenomenon referred to as legacy effect. Whether an early introduction of glucose-lowering drugs with pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceriello, Antonio, Lucisano, Giuseppe, Prattichizzo, Francesco, La Grotta, Rosalba, Frigé, Chiara, De Cosmo, Salvatore, Di Bartolo, Paolo, Di Cianni, Graziano, Fioretto, Paola, Giorda, Carlo Bruno, Pontremoli, Roberto, Russo, Giuseppina, Viazzi, Francesca, Nicolucci, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398589/
https://www.ncbi.nlm.nih.gov/pubmed/37547276
http://dx.doi.org/10.1016/j.lanepe.2023.100666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398589/
https://www.ncbi.nlm.nih.gov/pubmed/37547276
http://dx.doi.org/10.1016/j.lanepe.2023.100666

Ejemplares similares